SCHEMBL6155183

SCHEMBL6155183

CC(C)(C)c1ccc(C[N]c2cc(Cl)c(Cl)c(Cl)c2Cl)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
CA2 P00918 2/20 0.33
NPC1 O15118 1/20 0.33
GALR3 O60755 1/20 0.33
NR2F2 P24468 1/20 0.33
GPR183 P32249 1/20 0.33
RAB9A P51151 1/20 0.33
GPR35 Q9HC97 1/20 0.33
SCN9A Q15858 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
ESRRB O95718 1/20 0.33
ESRRG P62508 1/20 0.33
CA1 P00915 1/20 0.33
RAPGEF3 O95398 1/20 0.32
RAPGEF4 Q8WZA2 1/20 0.32
RXRA P19793 1/20 0.32
RXRB P28702 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6153549 0.70 CASP3 (0.38) NR1H4MEN1KMT2ACA2CYP1A2
SCHEMBL6155194 0.69 MEN1 (0.42) NR1H4MEN1KMT2ACA2CYP1A2
SCHEMBL21696714 0.64 ACHE (0.45) CA2CA1KCNH2TP53TSHR
SCHEMBL18717389 0.64 TSHR (0.46) NR1H4CA2CA1KCNH2TP53
SCHEMBL31156291 0.63 AHR (0.58) KMT2ANPC1RAB9ARAPGEF3RAPGEF4
SCHEMBL1204683 0.61 TSHR (0.48) MEN1KMT2ACA2CYP1A2CYP2C19
SCHEMBL30087039 0.61 TSHR (0.48) NR1H4CA2CA1KCNH2TP53
SCHEMBL5366000 0.61 TSHR (0.48) NR1H4ESRRBESRRGKCNH2TP53
SCHEMBL28964164 0.60 CA2 (0.63) MEN1KMT2ACA2CYP1A2CYP2C19
SCHEMBL13359294 0.60 APP (0.56) MEN1KMT2ANPC1RAB9ARXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP NR1H4 3991/4885MEN1 4329/4885KMT2A 875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.